Can K-ras codon 12 mutations be used to distinguish benign bile duct proliferations from metastases in the liver? A molecular analysis of 101 liver lesions from 93 patients
Ralph H. Hruban, Patrick D.J. Sturm, Robbert J.C. Slebos, Robb E. Wilentz, Alex R. Musler, Charles J. Yeo, Taylor A. Sohn, Marie Louise F. Van Velthuysen, G. Johan A. Offerhaus
Research output: Contribution to journal › Article › peer-review
Dive into the research topics of 'Can K-ras codon 12 mutations be used to distinguish benign bile duct proliferations from metastases in the liver? A molecular analysis of 101 liver lesions from 93 patients'. Together they form a unique fingerprint.